Beatriz Brea Álvarez
Beatriz Brea Álvarez
Transient syndrome of inappropriate antidiuresis due to intracranial hematoma in a patient with partial antidiuretic hormone deficiency and Steinert's dystrophy [0.03%]
部分抗利尿激素缺乏和Steinert病患者的颅内血肿引起的抗利尿激素不适当分泌综合征的短暂症状群
Guillermo Ropero-Luis,Viyey Kishore Doulatram-Gamgaram
Guillermo Ropero-Luis
A novel approach to finding the compositional differences and biomarkers in gut microbiota in type 2 diabetic patients via meta-analysis, data-mining, and multivariate analysis [0.03%]
基于元分析、数据挖掘及多因素分析的2型糖尿病患者肠道菌群差异及生物标记物的研究
Faezeh Ebrahimi,Hadi Maleki,Mansour Ebrahimi et al.
Faezeh Ebrahimi et al.
Background/purpose of the study: Type 2 diabetes mellitus (T2DM)-one of the fastest globally spreading diseases-is a chronic metabolic disorder characterized by elevated blood glucose levels. It has been suggested that th...
Predictors of length of hospital stay in patients presenting to the emergency department with hyperosmolar hyperglycemic crises [0.03%]
急诊科高渗性高血糖危象患者住院时间的预测因素分析
Tomás González-Vidal,Diego Rivas-Otero,Carmen Lambert et al.
Tomás González-Vidal et al.
Objective: To predict the length of hospital stay in hyperosmolar hyperglycemic crises (HHC) using variables available on admission. Methods: ...
Ectopic adrenocorticotropic hormone syndrome due to olfactory neuroblastoma: A case report and literature review [0.03%]
异位促肾上腺皮质激素综合征由嗅神经母细胞瘤所致的一例报告及文献复习
Mónica Baptista Lopes,Ricardo Fonseca,João Fernandes Serôdio et al.
Mónica Baptista Lopes et al.
Ectopic adrenocorticotropic hormone (ACTH) syndrome (EAS) is a cause of Cushing's syndrome usually associated with neuroendocrine tumors. Olfactory neuroblastoma (ONB) is a rare malignant neoplasm of the olfactory epithelium. This is the ca...
Adipopathy and dysglycaemia in systemic metabolic disease: Towards an integrated multidisciplinary approach led by the endocrinologist [0.03%]
内分泌科医生牵头的系统代谢病脂肪病和糖代谢异常的综合多学科诊治
Núria Alonso,María Teresa Julián
Núria Alonso
CANTCAM project (ANaplastic Thyroid Carcinoma in CAstilla-La Mancha). Multicenter retrospective study [0.03%]
CANTCAM项目（LA Castilla-La Mancha地区间变性甲状腺癌的回顾性多中心研究）
Sandra Herranz-Antolín,Rosa Quílez-Toboso,Jesús Moreno-Fernández et al.
Sandra Herranz-Antolín et al.
Objective: To analyze the clinical presentation, diagnosis, management and survival of Anaplastic Thyroid Carcinomas (ATC) in the Hospitals of Castilla-La Mancha (Spain). ...
Real-world evaluation of the efficacy and safety of switching from weekly dulaglutide to weekly semaglutide: The SEMA-SWITCH study [0.03%]
德谷胰岛素换用索马鲁肽的疗效和安全性的真实世界评价：SEMA-SWITCH研究
Felipe Pardo Lozano,Arantxa Rubio Marcos,Rosa Casañ Fernández et al.
Felipe Pardo Lozano et al.
Introduction: Dulaglutide and semaglutide are once-weekly administered GLP-1 receptor agonists (GLP-1 RAs) indicated for the treatment of hyperglycemia in individuals with type 2 diabetes mellitus (T2DM) and obesity (BMI ...
Sodium evolution in hyponatremia: A retrospective analysis in a tertiary care center [0.03%]
特护中心低钠血症患者钠水平变化的回顾性分析
Karina Mercedes Becerra Añez,Carlos Sánchez Juan,Ana Artero Fullana et al.
Karina Mercedes Becerra Añez et al.
Introduction: Hyponatremia is the most common electrolyte disorder in hospitals. This study analyses the evolution of serum sodium levels during hospitalization. ...
Effect of glucagon-like peptide-1 receptor agonists on the risk of major adverse limb events in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized clinical trials [0.03%]
胰高血糖素样肽-1受体激动剂对2型糖尿病患者下肢主要不良事件风险的影响：随机临床试验的系统评价和meta分析
Fernando Garagoli,Walter Masson,Leandro Barbagelata et al.
Fernando Garagoli et al.
Objective: To evaluate the effect of glucagon-like peptide-1 receptor agonists (GLP-1RAs) on the risk of major adverse limb events (MALE). Methods: ...